Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib

被引：0
|
作者：
Yuko Oya
Tatsuya Yoshida
Kazuhiro Asada
Tetsuya Oguri
Naoki Inui
Sayako Morikawa
Kentaro Ito
Tomoki Kimura
Eiji Kunii
Takashi Matsui
Akihito Kubo
Tatsuo Kato
Takashi Abe
Takeshi Tsuda
Toyoaki Hida
机构：
[1] Aichi Cancer Center Hospital,Department of Thoracic Oncology
[2] National Cancer Center Hospital,Current Address: Department of Thoracic Oncology
[3] Shizuoka General Hospital,Department of Respiratory Medicine
[4] Nagoya City University,Department of Respiratory Medicine, Allergy and Clinical Immunology
[5] Hamamatsu University School of Medicine,Second Division, Department of Internal Medicine
[6] Fujita Health University School of Medicine,Department of Respiratory Medicine
[7] Matsusaka Municipal Hospital,Respiratory Center
[8] Tosei General Hospital,Department of Respiratory Medicine and Allergy
[9] Nagoya City West Medical Center,Department of Respiratory Medicine
[10] Seirei Mikatahara General Hospital,Department of Respiratory Medicine
[11] Aichi Medical University School of Medicine,Division of Respiratory Medicine and Allergology
[12] National Hospital Organization Nagara Medical Center,Department of Respiratory Medicine
[13] Ogaki Municipal Hospital,Department of Respiratory Medicine
[14] Toyama Prefectural Central Hospital,Department of Respiratory Medicine
来源：
BMC Cancer | / 21卷
关键词：
Epidermal growth factor receptor (EGFR); EGFR-tyrosine kinase inhibitor; Non-small cell lung cancer (NSCLC); Afatinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] A Prospective Observational Study of Osimertinib Using Plasma Concentrations in NSCLC With Acquired EGFR T790M Mutation
    Nakagawa, T.
    Fukuhara, T.
    Imai, K.
    Igusa, R.
    Yokota, H.
    Watanabe, K.
    Suzuki, A.
    Morita, M.
    Inoue, A.
    Miura, M.
    Minamiya, Y.
    Maemondo, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S953 - S954
  • [42] Mechanisms of acquired resistance to osimertinib in advanced NSCLC with EGFR T790M mutation (LOGIK1607)
    Yamaguchi, Masafumi
    Osoegawa, Atsushi
    Nakamura, Tomomi
    Morinaga, Ryotaro
    Tanaka, Kentaro
    Kashiwabara, Kosuke
    Miura, Takashi
    Suetsugu, Takayuki
    Taguchi, Kenichi
    Nabeshima, Kazuki
    Kishimoto, Junji
    Sakai, Kazuko
    Nishio, Kazuto
    Sugio, Kenji
    CANCER SCIENCE, 2021, 112 : 567 - 567
  • [43] EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy
    Kim, Minhye
    Na, Ji Min
    Lee, Gyeong-Won
    Lee, Seung Jun
    Kim, Jong Duk
    Yang, Jung Wook
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2021, 55 (01) : 79 - 82
  • [44] Acquired resistance of pulmonary adenocarcinoma to initially successful targeted therapy due to EGFR mutation T790M
    Jancarikova, D.
    Pesek, M.
    Benesova, L.
    Topolcan, O.
    Holubec, L., Jr.
    Minarik, M.
    ANTICANCER RESEARCH, 2007, 27 (4A) : 1879 - 1882
  • [45] Lung Adenocarcinoma with Double Heterozygote EGFR mutation and Combined Resistance: ALK Translocation and EGFR T790M
    Denninghoff, V.
    Wainsztein, V.
    Cuello, M. T.
    Recondo, G.
    Rojas Bilbao, E.
    Avagnina, A.
    Recondo, G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S179 - S179
  • [46] A Rapid and Sensitive Method for Detection of the T790M Mutation of EGFR in Plasma DNA
    Kimura, Hideharu
    Nishikawa, Shingo
    Koba, Hayato
    Yoneda, Taro
    Sone, Takashi
    Kasahara, Kazuo
    CIRCULATING NUCLEIC ACIDS IN SERUM AND PLASMA - CNAPS IX, 2016, 924 : 171 - 174
  • [47] Dynamics of Plasma EGFR T790M Mutation in Advanced NSCLC: A Multicenter Study
    Yang, Zhengquan
    Li, Jialu
    Hu, Yujie
    Chen, Meihua
    Peng, Danli
    Zong, Dan
    Shang, Qingjuan
    Tao, Lianqin
    Zhao, Yanling
    Ni, Yiyun
    Ye, Jinyan
    Xie, Yupeng
    Yang, Li
    Lin, Quan
    Cai, Chang
    Xu, Ning
    Huang, Xiaoping
    Dong, Xiaoting
    Zhou, Zhonghui
    Yu, Yali
    Shangguan, Zongxiao
    Xu, Yangyang
    Ying, Weiping
    Weng, Meiling
    Yuan, Zuguo
    Dong, Zhijun
    Li, Jifa
    Zheng, Zhe
    Pan, Jiongwei
    Liu, Lu
    Ye, Junhui
    Zhang, Zhan
    Li, Wenfeng
    Zhu, Junfei
    Jin, Shengnan
    Li, Yuping
    Ding, Chunming
    TARGETED ONCOLOGY, 2019, 14 (06) : 719 - 728
  • [48] The emergence of T790M mutation in EGFR-mutant lung adenocarcinoma patients having a history of acquired resistance to EGFR-TKI: focus on rebiopsy timing and long-term existence of T790M
    Tseng, Jeng-Sen
    Su, Kang-Yi
    Yang, Tsung-Ying
    Chen, Kun-Chieh
    Hsu, Kuo-Hsuan
    Chen, Hsuan-Yu
    Tsai, Chi-Ren
    Yu, Sung-Liang
    Chang, Gee-Chen
    ONCOTARGET, 2016, 7 (30) : 48059 - 48069
  • [49] Retrospective Analysis of the Impact of EGFR T790M Mutation Detection by Re-Biopsy in Patients with NSCLC Harboring EGFR Mutations
    Okura, N.
    Yamada, T.
    Yoshimura, A.
    Takeda, T.
    Kubota, Y.
    Shiotsu, S.
    Hiranuma, O.
    Uchino, J.
    Takayama, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S897 - S898
  • [50] Bronchoalveolar Lavage as an Alternative to Rebiopsy for Detection of T790M Mutation in NSCLC Patients with Acquired Resistance to EGFR-TKIs
    Kim, H.
    Hur, J. Y.
    Kim, I. A.
    Lee, S.
    Kim, W. S.
    Lee, K. Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S368 - S368
12345